| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |